Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

BMC Blood Disorders
M StanullaMartin Schrappe

Abstract

BACKGROUND: Circulating levels of tumor necrosis factor (TNF) and lymphotoxin-alpha (LT-alpha) have been associated with outcome in solid and hematologic malignancies. Within the TNF gene and the LT-alpha gene, polymorphisms have been identified at nucleotide positions -308 and +252, respectively. The variant alleles for TNF are designated TNF1 and TNF2, the ones for LT-alpha LT-alpha (10.5 kb) and LT-alpha (5.5 kb). Of interest, TNF2 and LT-alpha (5.5 kb) were shown to be associated with higher TNF and LT-alpha plasma levels than their counterparts. In the present study, we investigated the associations of the above mentioned polymorphisms with risk of relapse in childhood acute lymphoblastic leukemia (ALL) treated according to Berlin-Frankfurt-Münster (BFM) protocols. METHODS: Matched case-control study of 64 relapsed and 64 successfully treated non-relapsed childhood B-cell precursor ALL patients of standard and intermediate risk for treatment failure. RESULTS: The odds ratio (OR) for the combined category of TNF1/TNF2 and TNF2/TNF2 genotypes in comparison to the TNF1/TNF1 genotype was 1.17 (95 % confidence interval (CI) = 0.53 - 2.56, P = 0.697). The ORs for the LT-alpha (10.5 kb/5.5 kb) and the LT-alpha (5.5 kb/5.5 kb) gen...Continue Reading

References

Nov 1, 1995·The Journal of Experimental Medicine·M CabreraJ M Blackwell
Jun 27, 1996·The New England Journal of Medicine·F Bazzoni, B Beutler
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K WarzochaB Coiffier
Jul 29, 1998·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·N WatanabeY Niitsu
Feb 19, 2005·International Journal of Hematology·Martin StanullaMatthias Schwab

❮ Previous
Next ❯

Citations

May 15, 2004·British Journal of Haematology·Richard Aplenc, Beverly Lange
Oct 13, 2007·Expert Opinion on Pharmacotherapy·Lea Cunningham, Richard Aplenc
Feb 15, 2011·Critical Care Medicine·Christoph HärtelUNKNOWN German Neonatal Network
Nov 21, 2007·Médecine sciences : M/S·Marc AnsariMaja Krajinovic
Oct 24, 2007·Journal of Clinical Periodontology·Chiara ScapoliLeonardo Trombelli
Nov 8, 2006·European Journal of Haematology·Besma Bel Hadj JradLotfi Chouchane

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

SAS
- PC

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.